Back to search
FDAFDA · Food and drugs·Recall number D-1322-2020

Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42

Published June 24, 2020 · Recall initiated: May 28, 2020

Summary

FDA records drug Class II recall D-1322-2020, published June 24, 2020 and initiated May 28, 2020. Recalling firm: Glaxosmithkline Consumer Healthcare Holdings; Status: Terminated; Reported quantity: 119,364 bottles; Lot: Lot #: 8M17C1, Exp 11/30/2020; 9E30C1, Exp 4/30/2021; 9F05C1, Exp 4/30/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

What to do

Voluntary: Firm initiated · Letter

Get an email if GAVISCON has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GAVISCON
Manufacturer
Glaxosmithkline Consumer Healthcare Holdings
Distributor
U.S.A. Nationwide
Lot
Lot #: 8M17C1, Exp 11/30/2020; 9E30C1, Exp 4/30/2021; 9F05C1, Exp 4/30/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42 recalled?

Yes. FDA published recall D-1322-2020 on June 24, 2020. Reported hazard: Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GAVISCON.